Cargando…
Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10–49 years old: a population-based study from the National Health and Nutrition Examination Survey
We studied the prevalence of monoclonal gammopathy of undetermined significance (MGUS) in younger individuals, age 10–49 years, using samples from the National Health and Nutritional Examination Survey (NHANES) III. NHANES prevalence rates were standardized to the 2000 US total population. Among 12 ...
Autores principales: | Landgren, O, Graubard, B I, Kumar, S, Kyle, R A, Katzmann, J A, Murata, K, Costello, R, Dispenzieri, A, Caporaso, N, Mailankody, S, Korde, N, Hultcrantz, M, Therneau, T M, Larson, D R, Cerhan, J R, Rajkumar, S V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678222/ https://www.ncbi.nlm.nih.gov/pubmed/29053158 http://dx.doi.org/10.1038/bcj.2017.97 |
Ejemplares similares
-
Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement
por: Murray, David, et al.
Publicado: (2019) -
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)
por: Pang, Li, et al.
Publicado: (2021) -
Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significance
por: Ryu, Alexander J., et al.
Publicado: (2023) -
Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota
por: Kleinstern, Geffen, et al.
Publicado: (2022) -
Immunoglobulin abnormalities and monoclonal gammopathy of undetermined significance in uninfected and HIV-infected men
por: Breen, Elizabeth Crabb, et al.
Publicado: (2010)